Your browser doesn't support javascript.
loading
Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort Study.
Seery, Nabil; Sharmin, Sifat; Li, Vivien; Nguyen, Ai-Lan; Meaton, Claire; Atvars, Roberts; Taylor, Nicola; Tunnell, Kelsey; Carey, John; Marriott, Mark P; Buzzard, Katherine A; Roos, Izanne; Dwyer, Chris; Baker, Josephine; Taylor, Lisa; Spriggs, Kymble; Kilpatrick, Trevor J; Kalincik, Tomas; Monif, Mastura.
Affiliation
  • Seery N; Department of Neurology, Melbourne MS Centre, Royal Melbourne Hospital, Parkville, VIC, 3050, Australia.
  • Sharmin S; Clinical Outcomes Research Unit, University of Melbourne, Melbourne, VIC, 3010, Australia.
  • Li V; Department of Medicine, University of Melbourne, Melbourne, VIC, 3010, Australia.
  • Nguyen AL; Department of Neurology, Melbourne MS Centre, Royal Melbourne Hospital, Parkville, VIC, 3050, Australia.
  • Meaton C; Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, VIC, 3052, Australia.
  • Atvars R; Department of Neurology, Melbourne MS Centre, Royal Melbourne Hospital, Parkville, VIC, 3050, Australia.
  • Taylor N; Clinical Outcomes Research Unit, University of Melbourne, Melbourne, VIC, 3010, Australia.
  • Tunnell K; Department of Medicine, University of Melbourne, Melbourne, VIC, 3010, Australia.
  • Carey J; Department of Neurology, Melbourne MS Centre, Royal Melbourne Hospital, Parkville, VIC, 3050, Australia.
  • Marriott MP; Department of Neurology, Melbourne MS Centre, Royal Melbourne Hospital, Parkville, VIC, 3050, Australia.
  • Buzzard KA; Day Medical Centre, Royal Melbourne Hospital, Parkville, VIC, 3050, Australia.
  • Roos I; Day Medical Centre, Royal Melbourne Hospital, Parkville, VIC, 3050, Australia.
  • Dwyer C; Day Medical Centre, Royal Melbourne Hospital, Parkville, VIC, 3050, Australia.
  • Baker J; Department of Neurology, Melbourne MS Centre, Royal Melbourne Hospital, Parkville, VIC, 3050, Australia.
  • Taylor L; Department of Neuroscience, Eastern Health Clinical School, Eastern Health, Box Hill, VIC, 3128, Australia.
  • Spriggs K; Department of Neurology, Melbourne MS Centre, Royal Melbourne Hospital, Parkville, VIC, 3050, Australia.
  • Kilpatrick TJ; Department of Neuroscience, Eastern Health Clinical School, Eastern Health, Box Hill, VIC, 3128, Australia.
  • Kalincik T; Department of Neurology, Melbourne MS Centre, Royal Melbourne Hospital, Parkville, VIC, 3050, Australia.
  • Monif M; Clinical Outcomes Research Unit, University of Melbourne, Melbourne, VIC, 3010, Australia.
CNS Drugs ; 35(8): 907-918, 2021 08.
Article in En | MEDLINE | ID: mdl-33847902
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Monoclonal, Humanized / Immunologic Factors / Infections / Multiple Sclerosis Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: CNS Drugs Journal subject: FARMACOLOGIA / NEUROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2021 Document type: Article Affiliation country: Australia Country of publication: Nueva Zelanda
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Monoclonal, Humanized / Immunologic Factors / Infections / Multiple Sclerosis Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: CNS Drugs Journal subject: FARMACOLOGIA / NEUROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2021 Document type: Article Affiliation country: Australia Country of publication: Nueva Zelanda